Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (731-740 of 762) with videos related to

Pageof 77
Sort By:
Journal of Medicinal Chemistry|February 21, 2022
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsStefano Tomassi, Marilisa Pia Dimmito, Minying Cai, et al.
Journal of Medicinal Chemistry|June 22, 2010
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
International Journal of Sport Nutrition|June 11, 1999
Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football playersM H Stone, K Sanborn, L L Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2013
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activitiesPadma Nair, Takashi Yamamoto, Tally M Largent-Milnes, et al.
European Journal of Pharmacology|May 12, 1997
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptorR M Quock, Y Hosohata, R J Knapp, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel cyclic biphalin analogue with improved antinociceptive propertiesAdriano Mollica, Alfonso Carotenuto, Ettore Novellino, et al.
Journal of Medicinal Chemistry|October 15, 2015
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of PainAswini Kumar Giri, Christopher R Apostol, Yue Wang, et al.
Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.
Journal of Medicinal Chemistry|February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Josef Vagner, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor AgonistsJonathon R Sawyer, Joseph A Audie, Jon Swanson, et al.
Pageof 77

Showing results (731-740 of 762) with videos related to

Sort By:
Pageof 77
Journal of Medicinal Chemistry|February 21, 2022
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsStefano Tomassi, Marilisa Pia Dimmito, Minying Cai, et al.
Journal of Medicinal Chemistry|June 22, 2010
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
International Journal of Sport Nutrition|June 11, 1999
Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football playersM H Stone, K Sanborn, L L Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2013
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activitiesPadma Nair, Takashi Yamamoto, Tally M Largent-Milnes, et al.
European Journal of Pharmacology|May 12, 1997
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptorR M Quock, Y Hosohata, R J Knapp, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel cyclic biphalin analogue with improved antinociceptive propertiesAdriano Mollica, Alfonso Carotenuto, Ettore Novellino, et al.
Journal of Medicinal Chemistry|October 15, 2015
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of PainAswini Kumar Giri, Christopher R Apostol, Yue Wang, et al.
Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.
Journal of Medicinal Chemistry|February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Josef Vagner, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor AgonistsJonathon R Sawyer, Joseph A Audie, Jon Swanson, et al.
Pageof 77